-
Servier Announces Positive Topline Data from the Global Phase 3 Study of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine in Patients with Previously Untreated IDH1-mutated Acute Myeloid
prnasia
August 02, 2021
Servier, a global pharmaceutical company, today announced the global Phase 3 double blinded placebo controlled AGILE study of TIBSOVO (ivosidenib tablets) in combination with the chemotherapy azacitidine in adults with previously untreated ...
-
GSK, Vir Biotechnology to evaluate neutralising Covid-19 antibody in AGILE study
pharmaceutical-business-review
January 14, 2021
GlaxoSmithKline, along with Vir Biotechnology, has agreed with the UK-based AGILE initiative to assess VIR-7832 in patients with mild to moderate Covid-19 in a phase 1b/2a clinical study.
-
New clinical trial platform launched to accelerate COVID-19 treatments
pharmatimes
July 09, 2020
The University of Liverpool, Liverpool School of Tropical Medicine and Southampton Clinical Trials Unit have launched an innovative COVID-19 drug testing platform, AGILE, in the hope of accelerating the development of the most promising therapies.
-
Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla
drugs
May 21, 2019
Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla.
-
Boehringer Ingelheim inaugurates new centre for agile working methods
worldpharmanews
November 01, 2018
Boehringer Ingelheim has taken an important step towards greater agility in the company with inauguration of the new building, called "BI CUBE", at the Ingelheim site.
-
Getting to True Agile IRT: 5 Questions to Ask Your IRT Vendor
fiercebiotech
May 02, 2018
The clinical randomization and supply chain management systems we now dub “IRT” were initially built as fully customized IT projects.